Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00432-009-0691-4, but it redirected us to https://link.springer.com/article/10.1007/s00432-009-0691-4. The analysis below is for the second page.

Title[redir]:
Loss of GDF-15 abolishes Sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer | Journal of Cancer Research and Clinical Oncology
Description:
Background Growth-differentiation factor (GDF)-15, a member of the TGF-beta superfamily, is potently induced in the intestine following mechanical injury, genotoxic insult and following non-steroidal anti-inflammatory drugs (NSAIDs) exposure. GDF-15 expression correlates with apoptosis in intestinal cells and has been implicated in the pathogenesis of colorectal cancer formation and the anti-tumor effects of NSAIDs. We sought to determine the effect of loss of Gdf15 on animal tumor models of hereditary colon cancer and in the NSAID-mediated prevention of heritable colorectal cancer. Methods GDF-15 null (Gdf15 βˆ’/βˆ’) mice and mice with the genetic mutation found in hereditary poliposis coli, Apc min/+ were bred. Gdf15 βˆ’/βˆ’ , Apc min/+ and Gdf15 +/+ , Apc min/+ mice were generated. Results In Gdf15 βˆ’/βˆ’ , Apc min/+ mice, intestinal neoplasia formation rate and size were indistinguishable from that in Gdf15 +/+ , Apc min/+ mice. Sulindac chemoprotection activity although potent in Gdf15 +/+ , Apc min/+ mice was abolished in Gdf15 βˆ’/βˆ’ , Apc min/+ mice. Conclusions These results demonstrate in a murine model that GDF-15 does not significantly regulate heritable in vivo intestinal carcinogenesis but does mediate sulindac chemoprevention in heritable colon cancer. These data suggest that the use of GDF-15 activated signaling pathways may allow improved chemoprevention and therapies for colorectal cancer.

Matching Content Categories {πŸ“š}

  • Health & Fitness
  • Education
  • Science

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We don't see any clear sign of profit-making.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org has a secret sauce for making money, but we can't detect it yet.

Keywords {πŸ”}

cancer, article, google, scholar, pubmed, cas, gdf, koniaris, zimmers, kim, sulindac, expression, colorectal, mice, min, nonsteroidal, antiinflammatory, colon, lee, gene, res, chemoprevention, intestinal, factor, apc, cell, research, mouse, gutierrez, injury, apoptosis, carcinogenesis, access, eling, growth, privacy, cookies, content, journal, model, member, superfamily, cells, gastric, induction, baek, cyclooxygenase, inhibitors, drugactivated, vogelstein,

Topics {βœ’οΈ}

steroidal anti-inflammatory drugs tgf-beta superfamily member month download article/chapter mic-1/growth differentiation factor-15 tgf-beta superfamily akt/gsk3beta/nag-1 pathway growth-differentiation factor 15 growth differentiation factor-15 colon cancer prevention nsaid-mediated prevention full article pdf hereditary colon cancer heritable colon cancer anti-tumor effects familial adenomatous polyposis colorectal cancer formation heritable colorectal cancer sinonasal cancer cells hereditary colorectal cancer mediate sulindac chemoprevention sulindac suppresses tumorigenesis privacy choices/manage cookies related subjects cox-2 specific inhibitors hereditary poliposis coli sulindac chemoprotection activity cancer prevention casero ra jr malignant colorectal tumors human cdna encoding clinical oncology aims celecoxib induces apoptosis brown ta colon cancer cyclooxygenase-independent induction mic-1 serum level article zimmers apcmin/+ mouse model cyclooxygenase inhibitors regulate european economic area animal tumor models genetic mutation found significantly regulate heritable check access instant access article journal spontaneous intestinal adenomas colorectal cancer conditions privacy policy cancer research

Questions {❓}

  • Zimmers TA, Gutierrez JC, Koniaris LG (2007) NAG-1/GDF-15: no evidence for an inhibitory role in colon cancer?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Loss of GDF-15 abolishes Sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer
         description:Growth-differentiation factor (GDF)-15, a member of the TGF-beta superfamily, is potently induced in the intestine following mechanical injury, genotoxic insult and following non-steroidal anti-inflammatory drugs (NSAIDs) exposure. GDF-15 expression correlates with apoptosis in intestinal cells and has been implicated in the pathogenesis of colorectal cancer formation and the anti-tumor effects of NSAIDs. We sought to determine the effect of loss of Gdf15 on animal tumor models of hereditary colon cancer and in the NSAID-mediated prevention of heritable colorectal cancer. GDF-15 null (Gdf15 βˆ’/βˆ’) mice and mice with the genetic mutation found in hereditary poliposis coli, Apc min/+ were bred. Gdf15 βˆ’/βˆ’ , Apc min/+ and Gdf15 +/+ , Apc min/+ mice were generated. In Gdf15 βˆ’/βˆ’ , Apc min/+ mice, intestinal neoplasia formation rate and size were indistinguishable from that in Gdf15 +/+ , Apc min/+ mice. Sulindac chemoprotection activity although potent in Gdf15 +/+ , Apc min/+ mice was abolished in Gdf15 βˆ’/βˆ’ , Apc min/+ mice. These results demonstrate in a murine model that GDF-15 does not significantly regulate heritable in vivo intestinal carcinogenesis but does mediate sulindac chemoprevention in heritable colon cancer. These data suggest that the use of GDF-15 activated signaling pathways may allow improved chemoprevention and therapies for colorectal cancer.
         datePublished:2009-09-27T00:00:00Z
         dateModified:2009-09-27T00:00:00Z
         pageStart:571
         pageEnd:576
         sameAs:https://doi.org/10.1007/s00432-009-0691-4
         keywords:
            NSAID
            Colon cancer
            COX-2
            Cytokine
            TGF-beta
            Oncology
            Cancer Research
            Internal Medicine
            Hematology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-009-0691-4/MediaObjects/432_2009_691_Fig1_HTML.gif
         isPartOf:
            name:Journal of Cancer Research and Clinical Oncology
            issn:
               1432-1335
               0171-5216
            volumeNumber:136
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Teresa A. Zimmers
               affiliation:
                     name:University of Miami Miller School of Medicine
                     address:
                        name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Miami Miller School of Medicine
                     address:
                        name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Juan C. Gutierrez
               affiliation:
                     name:University of Miami Miller School of Medicine
                     address:
                        name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Leonidas G. Koniaris
               affiliation:
                     name:University of Miami Miller School of Medicine
                     address:
                        name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Miami Miller School of Medicine
                     address:
                        name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Loss of GDF-15 abolishes Sulindac chemoprevention in the ApcMin/+ mouse model of intestinal cancer
      description:Growth-differentiation factor (GDF)-15, a member of the TGF-beta superfamily, is potently induced in the intestine following mechanical injury, genotoxic insult and following non-steroidal anti-inflammatory drugs (NSAIDs) exposure. GDF-15 expression correlates with apoptosis in intestinal cells and has been implicated in the pathogenesis of colorectal cancer formation and the anti-tumor effects of NSAIDs. We sought to determine the effect of loss of Gdf15 on animal tumor models of hereditary colon cancer and in the NSAID-mediated prevention of heritable colorectal cancer. GDF-15 null (Gdf15 βˆ’/βˆ’) mice and mice with the genetic mutation found in hereditary poliposis coli, Apc min/+ were bred. Gdf15 βˆ’/βˆ’ , Apc min/+ and Gdf15 +/+ , Apc min/+ mice were generated. In Gdf15 βˆ’/βˆ’ , Apc min/+ mice, intestinal neoplasia formation rate and size were indistinguishable from that in Gdf15 +/+ , Apc min/+ mice. Sulindac chemoprotection activity although potent in Gdf15 +/+ , Apc min/+ mice was abolished in Gdf15 βˆ’/βˆ’ , Apc min/+ mice. These results demonstrate in a murine model that GDF-15 does not significantly regulate heritable in vivo intestinal carcinogenesis but does mediate sulindac chemoprevention in heritable colon cancer. These data suggest that the use of GDF-15 activated signaling pathways may allow improved chemoprevention and therapies for colorectal cancer.
      datePublished:2009-09-27T00:00:00Z
      dateModified:2009-09-27T00:00:00Z
      pageStart:571
      pageEnd:576
      sameAs:https://doi.org/10.1007/s00432-009-0691-4
      keywords:
         NSAID
         Colon cancer
         COX-2
         Cytokine
         TGF-beta
         Oncology
         Cancer Research
         Internal Medicine
         Hematology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-009-0691-4/MediaObjects/432_2009_691_Fig1_HTML.gif
      isPartOf:
         name:Journal of Cancer Research and Clinical Oncology
         issn:
            1432-1335
            0171-5216
         volumeNumber:136
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Teresa A. Zimmers
            affiliation:
                  name:University of Miami Miller School of Medicine
                  address:
                     name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Miami Miller School of Medicine
                  address:
                     name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Juan C. Gutierrez
            affiliation:
                  name:University of Miami Miller School of Medicine
                  address:
                     name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Leonidas G. Koniaris
            affiliation:
                  name:University of Miami Miller School of Medicine
                  address:
                     name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Miami Miller School of Medicine
                  address:
                     name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Cancer Research and Clinical Oncology
      issn:
         1432-1335
         0171-5216
      volumeNumber:136
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Miami Miller School of Medicine
      address:
         name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
         type:PostalAddress
      name:University of Miami Miller School of Medicine
      address:
         name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
         type:PostalAddress
      name:University of Miami Miller School of Medicine
      address:
         name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
         type:PostalAddress
      name:University of Miami Miller School of Medicine
      address:
         name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
         type:PostalAddress
      name:University of Miami Miller School of Medicine
      address:
         name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Teresa A. Zimmers
      affiliation:
            name:University of Miami Miller School of Medicine
            address:
               name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
               type:PostalAddress
            type:Organization
            name:University of Miami Miller School of Medicine
            address:
               name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Juan C. Gutierrez
      affiliation:
            name:University of Miami Miller School of Medicine
            address:
               name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
               type:PostalAddress
            type:Organization
      name:Leonidas G. Koniaris
      affiliation:
            name:University of Miami Miller School of Medicine
            address:
               name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
               type:PostalAddress
            type:Organization
            name:University of Miami Miller School of Medicine
            address:
               name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
      name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
      name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
      name:Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, USA
      name:Department of Cell Biology and Anatomy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(167)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {πŸ“¦}

  • Crossref

4.8s.